U.S.-LISTED SHARES OF REDHILL BIOPHARMA RISE 2.4% ON ADDITIONAL FUNDING FOR MID-STAGE STUDY OF COVID DRUG
U.s.-Listed Shares Of Redhill Biopharma Rise 2.4% On Additional…
![Reuters logo](/images/reuters.jpg)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3626 USD | +0.17% |
|
-3.87% | -75.16% |
Jun. 06 | RedHill Biopharma Ltd. Announces Resignation of Alla Felders as Member of the Board | CI |
May. 06 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
U.S.-LISTED SHARES OF REDHILL BIOPHARMA RISE 2.4% ON ADDITIONAL FUNDING FOR MID-STAGE STUDY OF COVID DRUG
1st Jan change | Capi. | |
---|---|---|
-75.16% | 11.55M | |
+4.57% | 96.72B | |
+5.66% | 41.43B | |
-13.20% | 32.7B | |
+82.51% | 29.06B | |
-16.02% | 15.38B | |
-8.17% | 12.97B | |
-13.35% | 11.36B | |
+160.91% | 9.9B | |
+3.07% | 8.93B |